|
1
|
Deng S, Vatamaniuk M, Huang X, Doliba N,
Lian MM, Frank A, Velidedeoglu E, Desai NM, Koeberlein B, Wolf B,
et al: Structural and functional abnormalities in the islets
isolated from type 2 diabetic subjects. Diabetes. 53:624–632. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Prentki M and Nolan CJ: Islet beta cell
failure in type 2 diabetes. J Clin Invest. 116:1802–1812. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Nyblom HK, Bugliani M, Fung E, Boggi U,
Zubarev R, Marchetti P and Bergsten P: Apoptotic, regenerative, and
immune-related signaling in human islets from type 2 diabetes
individuals. J Proteome Res. 8:5650–5656. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Misfeldt A, Costa RH and Gannon M:
Beta-cell proliferation, but not neogenesis, following 60% partial
pancreatectomy is impaired in the absence of FoxM1. Diabetes.
57:3069–3077. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Barr FA, Silljé HH and Nigg EA: Polo-like
kinases and the orchestration of cell division. Nat Rev Mol Cell
Biol. 5:429–440. 2004. View
Article : Google Scholar : PubMed/NCBI
|
|
6
|
Zitouni S, Nabais C, Jana SC, Guerrero A
and Bettencourt-Dias M: Bettencourt-Dias M. Polo-like kinases:
Structural variations lead to multiple functions. Nat Rev Mol Cell
Biol. 15:433–452. 2014. View
Article : Google Scholar : PubMed/NCBI
|
|
7
|
Bruinsma W, Raaijmakers JA and Medema RH:
Switching Polo-like kinase-1 on and off in time and space. Trends
Biochem Sci. 37:534–542. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Petronczki M, Lénárt P and Peters JM: Polo
on the rise from mitotic entry to cytokinesis with Plk1. Dev Cell.
14:646–659. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Liu X and Erikson RL: Activation of
Cdc2/cyclin B and inhibition of centrosome amplification in cells
depleted of Plk1 by siRNA. Proc Natl Acad Sci USA. 99:8672–8676.
2002. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Lénárt P, Petronczki M, Steegmaier M, Di
Fiore B, Lipp JJ, Hoffmann M, Rettig WJ, Kraut N and Peters JM: The
small-molecule inhibitor BI 2536 reveals novel insights into
mitotic roles of polo-like kinase 1. Curr Biol. 17:304–315. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
de Cárcer G, Manning G and Malumbres M:
From Plk1 to Plk5: Functional evolution of polo-like kinases. Cell
Cycle. 10:2255–2262. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Strebhardt K and Ullrich A: Targeting
polo-like kinase 1 for cancer therapy. Nat Rev Cancer. 6:321–330.
2006. View
Article : Google Scholar : PubMed/NCBI
|
|
13
|
Eckerdt F, Yuan J and Strebhardt K:
Polo-like kinases and oncogenesis. Oncogene. 24:267–276. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Bassermann F, Frescas D, Guardavaccaro D,
Busino L, Peschiaroli A and Pagano M: The Cdc14B-Cdh1-Plk1 axis
controls the G2 DNA-damage-response checkpoint. Cell. 134:256–267.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Mocciaro A, Berdougo E, Zeng K, Black E,
Vagnarelli P, Earnshaw W, Gillespie D, Jallepalli P and Schiebel E:
Vertebrate cells genetically deficient for Cdc14A or Cdc14B retain
DNA damage checkpoint proficiency but are impaired in DNA repair. J
Cell Biol. 189:631–639. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Mocciaro A and Schiebel E: Cdc14: A highly
conserved family of phosphatases with non-conserved functions? J
Cell Sci. 123:2867–2876. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Chen NP, Uddin B, Voit R and Schiebel E:
Human phosphatase CDC14A is recruited to the cell leading edge to
regulate cell migration and adhesion. Proc Natl Acad Sci USA.
113:990–995. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Yuan K, Hu H, Guo Z, Fu G, Shaw AP, Hu R
and Yao X: Phospho-regulation of HsCdc14A By Polo-like kinase 1 is
essential for mitotic progression. J Biol Chem. 282:27414–27423.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Shapiro AM, Ricordi C, Hering BJ,
Auchincloss H, Lindblad R, Robertson RP, Secchi A, Brendel MD,
Berney T, Brennan DC, et al: International trial of the Edmonton
protocol for islet transplantation. N Engl J Med. 355:1318–1330.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Hanley NA, Hanley KP, Miettinen PJ and
Otonkoski T: Weighing up beta-cell mass in mice and humans:
Self-renewal, progenitors or stem cells? Mol Cell Endocrinol.
288:79–85. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Xu X, D'Hoker J, Stangé G, Bonné S, De Leu
N, Xiao X, Van de Casteele M, Mellitzer G, Ling Z, Pipeleers D, et
al: Beta cells can be generated from endogenous progenitors in
injured adult mouse pancreas. Cell. 132:197–207. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Rieck S, Zhang J, Li Z, Liu C, Naji A,
Takane KK, Fiaschi-Taesch NM, Stewart AF, Kushner JA and Kaestner
KH: Overexpression of hepatocyte nuclear factor-4α initiates cell
cycle entry, but is not sufficient to promote β-cell expansion in
human islets. Mol Endocrinol. 26:1590–1602. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Sharma A, Yerra VG and Kumar A: Emerging
role of Hippo signalling in pancreatic biology: YAP re-expression
and plausible link to islet cell apoptosis and replication.
Biochimie. 133:56–65. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
García-Ocaña A, Vasavada RC, Takane KK,
Cebrian A, Lopez-Talavera JC and Stewart AF: Using beta-cell growth
factors to enhance human pancreatic Islet transplantation. J Clin
Endocrinol Metab. 86:984–988. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Montaña E, Bonner-Weir S and Weir GC:
Transplanted beta cell response to increased metabolic demand.
Changes in beta cell replication and mass. J Clin Invest.
93:1577–1582. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Vasavada RC, Gonzalez-Pertusa J, Fujinaka
Y, Fiaschi-Taesch N, Cozar-Castellano I and Garcia-Ocaña A: Growth
factors and beta cell replication. Int J Biochem Cell Biol.
38:931–950. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Lowell BB and Shulman GI: Mitochondrial
dysfunction and type 2 diabetes. Science. 307:384–387. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Maedler K, Sergeev P, Ris F, Oberholzer J,
Joller-Jemelka HI, Spinas GA, Kaiser N, Halban PA and Donath MY:
Glucose-induced beta cell production of IL-1beta contributes to
glucotoxicity in human pancreatic islets. J Clin Invest.
110:851–860. 2002. View Article : Google Scholar : PubMed/NCBI
|
